Trial
NCT03981211
Treatment of HOsPitalised Inpatients for Hepatitis C (TOPIC): Therapeutic Intervention Enhancing Care Linkage in People Who Inject Drugs
UnknownTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Kirby Institute
Collaborators
—
Condition
Hepatitis C
Intervention
Glecaprevir/Pibrentasvir 100 MG-40 MG Oral Tablet
Why stopped
The study was impacted by the COVID-19 pandemic. Once recruitment recommenced it remained slow. Removal of Sofosbuvir from the PBS November 2020 impacted recruitment into Cohort B. Study closed early on 15-Sep-26.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-26